The integration of functional genomics, combinatorial chemistry and nanotechnology into a miniaturized drug discovery process

Single molecule fluorescence spectroscopy and confocal nanoscanning/AIDA technology provide an optimal combination for a miniaturized automated uHTS process with high mechanistic resolution in functional and coupled assay systems.